RenX Enterprises grants director 8,294 stock options

The director's options vest pro rata monthly over six months beginning November 13, 2026, provided he continues service through each vesting date.

Rhea-AI Filing Summary

RenX Enterprises Corp. (RENX) director J. Scott Magrane received a grant of 8,294 stock options on October 13, 2026. The options cover 8,294 common shares, have a $1.54 exercise price, and expire October 12, 2036. They vest pro rata monthly over six months beginning November 13, 2026, subject to continued service through each vesting date.

Insider Trade Summary

Grant/Award: 8,294 shares

Grant/Award 1 txn

Insider Magrane J. Scott

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option F1	8,294	$0.00	$0.00

Holdings After Transaction: Stock Option — 8,294 contracts (Direct)

Footnotes (1)

1. F1. The options vest pro rata on a monthly basis over six months commencing on November 13, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Key Figures

Stock options granted: 8,294 options Underlying common shares: 8,294 shares Exercise price: $1.54 per share +2 more

5 metrics

Stock options granted 8,294 options Grant to director J. Scott Magrane on October 13, 2026

Underlying common shares 8,294 shares Shares covered by the option grant

Exercise price $1.54 per share Options granted October 13, 2026

Options following grant 8,294 options Reported position after the October 13, 2026 transaction

Vesting period Six months Monthly vesting begins November 13, 2026, subject to continued service

Key Terms

pro rata, vesting date, exercise price

3 terms

pro rata technical

"vest pro rata on a monthly basis over six months"

Pro rata means dividing or distributing something proportionally based on a specific factor, such as ownership or contribution. For example, if an investor owns 10% of a company, they would receive 10% of any dividends or benefits allocated. This approach ensures everyone gets their fair share relative to their stake or input, helping investors understand how benefits, costs, or responsibilities are fairly shared.

vesting date technical

"through each vesting date"

exercise price financial

"exercise price of $1.54"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many options did RENX director J. Scott Magrane receive?

J. Scott Magrane, a director of RenX Enterprises Corp. (RENX), received 8,294 stock options on October 13, 2026, with an exercise price of $1.54 per share.

When do J. Scott Magrane's RENX options vest?

The options vest pro rata monthly over six months beginning November 13, 2026, subject to continued service through each vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/15/2026 - 05:32 PM EDT Accepted by SEC EDGAR 10/15/2026 - 05:32 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Magrane J. Scott

(Last) (First) (Middle)

C/O RENX ENTERPRISES CORP.

100 BISCAYNE BLVD., SUITE 1201

(Street)

MIAMI FLORIDA 33132

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RenX Enterprises Corp. [ RENX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option(1)	$1.54	10/13/2026		A		8,294		(1)	10/12/2036	Common Stock	8,294	$0	8,294	D

Explanation of Responses:

1. The options vest pro rata on a monthly basis over six months commencing on November 13, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.

	/s/ Nicolai Brune, Attorney-in-Fact	10/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)